News search

    E.g., 25/04/2024
    E.g., 25/04/2024
    Alejandro Salguero-Jiménez, Joaquim Grego-Bessa, Giovanna Giovinazzo, Fátima Sánchez-Cabo, Belén Prados, José Luis de la Pompa, Marcos Siguero-Álvarez, Sergio Callejas, Carlos Torroja, Ana Dopazo, Jorge de la Barrera, Donal MacGrogan y Manuel José Gómez.
    Research
    7 Nov 2022
    Circulation: Specific modifier genes determine the effect of mutations that cause non-compaction cardiomyopathy

    A CNIC study reveals that mutations previously identified in the gene MINDBOMB1 (MIB1) as causing non-compaction cardiomyopathy either provoke this disease or valve defects, depending on their combination with mutations in modifier genes

    Descubren un factor clave que protege el corazón tras un infarto
    About the CNIC
    2 Nov 2022
    JCI: CNIC scientists identify a factor that protects the heart against damage after a heart attack

    A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor

    Cellular and Molecular Sciences: Describen un nuevo mecanismo que relaciona la inflamación y el remodelado cardiovascular patológico
    Research
    29 Sep 2022
    Cellular and Molecular Sciences: Describing a new mechanism that links inflammation and pathological cardiovascular remodelling
    About the CNIC
    23 Aug 2022
    Cell Stem Cell: Researchers at CNIC, UPF, ICREA, CIBERNED and CIBERFES identify a mechanism that maintains mitochondria function in muscle stem cells and that can be stimulated in old age

    The finding provides a basis for mitigating the loss of muscle regenerative capacity in elderly people
    Dr. Pablo García-Pavía y Dr. Jesús Gonzalez Mirelis, codirectores del trabajo.
    Research
    22 Jul 2022
    EJHF: Spanish scientists combine genetic and imaging data to improve the treatment of dilated cardiomyopathy

    Genetic screening combined with the detection of fibrosis identifies patients at risk of malignant arrhythmias or developing heart failure with severe complications
    Enrique Calvo, Jesús Vázquez, Álvaro Alfayate, Estefanía Núñez y José Luis Martín Ventura.
    Research
    28 Mar 2022
    eBiomedicine: Spanish scientists discover a new method for the early detection of subclinical atherosclerosis

    A study published in the journal eBiomedicine identifies new biomarkers that predict the presence of subclinical atherosclerosis
    Álvaro Macías, Jesús Vázquez, Pilar Gonzalo, Carla Espinós, Beatriz Dorado, Emilio Camafeita, Vicente Andrés, María J Andrés, Cristina González, Amanda Sánchez, Víctor Fanjul.
    Research
    26 Oct 2021
    CIRCULATION: It's never too late to treat progeria

    Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal
    Research
    4 May 2020
    Cardiovascular Research: Spanish scientists discover how the flu virus injures the heart

    The study shows that the replication of flu virus particles infecting the heart blocks the transmission of cardiac electrical impulses
    De izquierda a derecha José Manuel Alfonso Almazán, Jorge García Quintanilla, Manuel Marina Breysse, José María Lillo Castellano, Julián Pérez Villacastín, David Filgueiras Rama, José Jalife y Nicasio Pérez Castellano.
    Research
    16 Dec 2019
    Europace: Personalized medicine for atrial fibrillation

    The study, published in Europace, uses signals from implantable devices—pacemakers and defibrillators—to analyze electrical signals in the heart during episodes of atrial fibrillation
    : Blood vessel duplications in the inflamed intestinal mucosa of a mouse with colitis.
    Research
    3 Dec 2019
    EMBO Molecular Medicine: Inhibiting a protease could improve the treatment of inflammatory bowel disease

    Scientists at the CNIC and CSIC have identified a function of a protease that could be the future target of drugs to treat inflammatory bowel disease